Why Russia? TGA took an extra two and half years to approve BIoA here because they didn't believe zero toxicity despite Russian trials -subsequently proved by the company BTW have you seen the "scientific " credentials of the TGA -they would make some of our downrampers appear intellectual. On the US the FDA is controlled by the major drug companies and is a major barrier to entry and approves stuff like Vioxx because of its corporate pedigree The company quite sensibly chose the market in which it has the most scientific credibility and frankly in all likelihood will produce the best outcome for shareholders. None of the trials done in Russia have been invalidated by subsequent duplication in the west . In the 5 years since listing the company has had a pharmaceutical approved for sale in a major market and is within sight of significant sales-don't know any other Bio that has done that from ground zero do you?
SLA Price at posting:
37.0¢ Sentiment: Buy Disclosure: Held
